These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 28604475)
1. Analysis of the Variables Influencing Valproic Acid Concentration in the Serum and Cerebrospinal Fluid of Chinese Patients After Craniotomy. Li Z; Gao W; Liu G; Chen W Ther Drug Monit; 2017 Aug; 39(4):450-456. PubMed ID: 28604475 [TBL] [Abstract][Full Text] [Related]
2. Prediction of Serum-Free and Cerebrospinal Fluid Valproic Acid Levels in Patients With Hypoalbuminemia After Craniotomy. Li Z; Gao W; Liu G; Chen W Ther Drug Monit; 2020 Aug; 42(4):610-616. PubMed ID: 32106182 [TBL] [Abstract][Full Text] [Related]
3. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy. Guo Y; Hu C; He X; Qiu F; Zhao L Drug Metab Pharmacokinet; 2012; 27(5):536-42. PubMed ID: 23099353 [TBL] [Abstract][Full Text] [Related]
4. Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury. Sun Y; Yu J; Yuan Q; Wu X; Wu X; Hu J Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):85. PubMed ID: 28841884 [TBL] [Abstract][Full Text] [Related]
5. Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy. Zhao M; Chen Y; Wang M; Li G; Zhao L Ther Drug Monit; 2020 Oct; 42(5):760-765. PubMed ID: 32107351 [TBL] [Abstract][Full Text] [Related]
6. Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data. Smith RL; Haslemo T; Refsum H; Molden E Eur J Clin Pharmacol; 2016 Sep; 72(9):1099-104. PubMed ID: 27353638 [TBL] [Abstract][Full Text] [Related]
7. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis. Yoon HY; Ahn MH; Yee J; Lee N; Han JM; Gwak HS Eur J Clin Pharmacol; 2020 Aug; 76(8):1053-1058. PubMed ID: 32385545 [TBL] [Abstract][Full Text] [Related]
8. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110 [TBL] [Abstract][Full Text] [Related]
9. Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy. Löscher W; Nau H; Siemes H Epilepsia; 1988; 29(3):311-6. PubMed ID: 3131137 [TBL] [Abstract][Full Text] [Related]
10. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine. Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295 [TBL] [Abstract][Full Text] [Related]
11. Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy. Ma B; Yang K; Li X; Su N; Yu T; Zou Y; Xu X; Wang F; Cheng J; Yan Z; Chen T; Zhang L Ther Drug Monit; 2024 Aug; 46(4):503-511. PubMed ID: 38287884 [TBL] [Abstract][Full Text] [Related]
12. Effect of UGT2B7 genetic variants on serum valproic acid concentration. Ma H; Zhang T; Gong Z; Zhou B; Zou M; Xiao S; Zhu W Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):766-72. PubMed ID: 23981985 [TBL] [Abstract][Full Text] [Related]
13. Effects of UGT1A6 and GABRA1 on Standardized Valproic Acid Plasma Concentrations and Treatment Effect in Children With Epilepsy in China. Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F Ther Drug Monit; 2016 Dec; 38(6):738-743. PubMed ID: 27855134 [TBL] [Abstract][Full Text] [Related]
14. Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy. Wang C; Wang P; Yang LP; Pan J; Yang X; Ma HY Epilepsy Res; 2017 May; 132():64-69. PubMed ID: 28315807 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of CYP2C9-status guided valproic acid therapy in children. Bűdi T; Tóth K; Nagy A; Szever Z; Kiss Á; Temesvári M; Háfra E; Garami M; Tapodi A; Monostory K Epilepsia; 2015 Jun; 56(6):849-55. PubMed ID: 25967074 [TBL] [Abstract][Full Text] [Related]
16. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients. Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988 [TBL] [Abstract][Full Text] [Related]
17. Influence of Du Z; Xu H; Zhao P; Wang J; Xu Q; Liu M Xenobiotica; 2021 Jul; 51(7):859-864. PubMed ID: 34000957 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors. Xu S; Chen Y; Zhao M; Guo Y; Wang Z; Zhao L Eur J Pharm Sci; 2018 Sep; 122():170-178. PubMed ID: 29981400 [TBL] [Abstract][Full Text] [Related]
19. Relationship between serum concentration and dose of valproic acid during monotherapy in adult outpatients. Tisdale JE; Tsuyuki RT; Oles KS; Penry JK Ther Drug Monit; 1992 Oct; 14(5):416-23. PubMed ID: 1448851 [TBL] [Abstract][Full Text] [Related]
20. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients. Chu XM; Zhang LF; Wang GJ; Zhang SN; Zhou JH; Hao HP Eur J Clin Pharmacol; 2012 Oct; 68(10):1395-401. PubMed ID: 22476391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]